Valneva SE Withdraws Chikungunya Vaccine Applications, Shares Drop 7.7%
- Vaccine Withdrawal: Valneva SE has withdrawn its BLA and IND applications for the IXCHIQ Chikungunya vaccine due to an FDA suspension and review of new serious adverse events, leading to a 7.7% drop in pre-market trading to $9.29, indicating market concerns over its product prospects.
- Market Decline: U.S. stock futures are broadly lower, with Dow futures falling around 700 points, reflecting investor caution regarding economic outlook, which may impact overall market sentiment and exacerbate volatility in other stocks.
- Other Stock Movements: Shares of Rezolve AI PLC and POET Technologies Inc fell 15% and 11.2% respectively in pre-market trading, indicating widespread investor apprehension towards tech stocks, potentially prompting a reassessment of risk appetite.
- Tesla Update: Tesla's stock fell 2.7% to $425.75 in pre-market trading, despite CEO Elon Musk confirming that vehicles equipped with the AI4 chip will achieve unsupervised autonomous driving, suggesting insufficient market confidence in the electric vehicle sector.
Trade with 70% Backtested Accuracy
Analyst Views on POET
About POET
About the author

- Significant Revenue Growth: Poet Technologies reported Q4 2025 revenue of $341,202, a substantial increase from $29,032 in the same quarter last year, indicating strong market demand and execution capabilities in the optical module development sector.
- Narrowed Net Loss: The company posted a loss of $0.32 per share in Q4 2025, an improvement from the $0.50 loss per share in Q4 2024, reflecting positive progress in cost control and operational efficiency.
- Increased Production Orders: Management confirmed a $5 million production order for optical engines received last quarter, which not only strengthens the revenue base but also lays a solid foundation for future growth.
- Strong Stock Performance: Poet Technologies' stock surged 17.7% this week, although it remains down over 3% since the start of the year, indicating increased investor confidence in its growth potential despite current unprofitability.
- Significant Financial Improvement: Poet Technologies reported Q4 2025 revenue of $341,202, a substantial increase from $29,032 in the same period last year, demonstrating the company's successful transition from development to execution, which has bolstered investor confidence.
- Reduced Loss Per Share: The company reported a loss of $0.32 per share in Q4 2025, an improvement from the $0.50 loss per share in Q4 2024, indicating progress in cost control and revenue enhancement, which may attract more investor interest.
- Production Order Confirmation: Management confirmed a $5 million production order for optical engines received last quarter, reflecting market validation of its technology and laying a foundation for future revenue growth, thereby enhancing the company's competitive position.
- Stock Price Uptrend: Poet Technologies' stock price surged 17.7% this week, and despite the company still being unprofitable, the rise in stock price indicates market optimism about its future growth potential, which may draw more investor interest.
- Significant Financial Improvement: Poet Technologies reported Q4 2025 revenue of $341,202, a substantial increase from $29,032 in the same quarter last year, demonstrating a successful transition from development to execution that boosts investor confidence.
- Reduced Loss Per Share: The company reported a loss per share of $0.32 in Q4 2025, an improvement from $0.50 in Q4 2024, indicating positive progress in cost control and revenue enhancement.
- Confirmed Production Order: Management confirmed a $5 million production order for optical engines in the last quarter, reflecting market validation of its technology and laying a foundation for future revenue growth.
- Stock Price Surge: Poet Technologies' stock rose 17.7% last week, although it remains down over 3% since the beginning of the year, indicating market optimism about its growth potential despite the recent volatility.
Investor Reluctance: Investors have been hesitant to support POET Technologies, particularly in the technology sector, following a significant decline from its 52-week high of $9.41 to around $6.
Business Strategy Shift: POET is transitioning from development to commercialization and scaling production, aiming to establish itself as a packaging and integration platform in the photonics industry.
Execution Challenges: The company's potential is evident in its financials, but execution remains critical; success hinges on customer adoption and scaling production to generate meaningful revenue.
Market Sentiment: Current market sentiment is cautious, with traders treating POET's stock as a volatility event rather than a long-term investment, indicating a need for stronger evidence of customer adoption and business progress.
- Earnings Report Disappointment: POET Technologies reported a Q4 GAAP EPS of -$0.32, missing estimates by $0.26, indicating ongoing challenges in profitability that could undermine investor confidence.
- Significant Revenue Growth: Despite a remarkable year-over-year revenue increase of 1033.3% to $0.34 million, the figure still fell short of expectations by $0.16 million, suggesting volatility in revenue generation that may impact future funding capabilities.
- Negative Stock Reaction: Shares fell 2.53% in after-hours trading, reflecting market disappointment with the earnings results, which could lead to short-term investor sell-offs.
- Funding Plan Announced: The company revealed a $150 million registered direct offering of shares, highlighting its urgent need for capital, which may dilute existing shareholders' equity.
- Stock Volatility: Poet Technologies' shares have declined nearly 9% over the past few days, indicating investor preference for companies with tangible earnings rather than 'story stocks' like Poet, reflecting concerns about its profitability.
- Strategic Collaboration: Poet has entered a strategic collaboration with optoelectronic semiconductor maker Liteon Technology to develop advanced optical communication modules, with prototypes expected by year-end and production slated for next year, highlighting the company's commitment to technological innovation.
- Partnership Deepening: Poet is also deepening its existing partnership with optical technology firm Lessengers to develop an optical transceiver module for AI clusters, showcasing their pre-prototype at the Optical Fiber Communication Conference, which underscores its potential in the AI sector.
- Lack of Financial Details: Despite the seemingly positive partnership announcements, the absence of financial details suggests minimal or no immediate remuneration, leading to market skepticism about Poet's business model and prompting cautious investor reactions.











